Have the following Open Offers:
The o2h human health EIS Knowledge Intensive Fund
The investment focus of the HMRC approved knowledge intensive (“KI”) EIS fund is therapeutic drug opportunities or technologies that enable drug discovery with an emphasis on Artificial Intelligence (AI), with a UK wide geographic scope. Broadly this is grouped by category and field to identify a few of the possible areas of high scientific or market interest areas such as immuno-oncology, genomics or anti-ageing.
The o2h human health SEIS fund
The human health SEIS fund will invest in seed stage SEIS qualifying companies covering novel drug discovery along with enabling services, tools and AI Technologies.
Tel: 020 3870 2598